巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Agilent Technologies

    A
    132.570
    3.740
    2.90%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Agilent Technologies - 延遲價格・最後更新於 10/08 9:30
    最高位
    132.760
    最低位
    130.360
    開市價
    --
    前收市價
    128.830
    成交量(千)
    50.66
    成交額(百萬)
    56.23
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    39,599.73
    市盈率
    32.020
    息率
    0.62%
    差價
    --
    52週高低
    179.570 - 112.520
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Agilent Technologies
    證券代碼
    A.US
    所屬板塊
    Diagnostics & Research
    公司業務
    Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
    發行量
    298708056
    公司總部
    5301 Stevens Creek Boulevard
    公司網址
    https://www.agilent.com
    公司電郵
    investor_relations@agilent.com
    公司電話
    +1 800 227-9770
    暫無內容

    關於

    Agilent Technologies(A.US)所屬的行業板塊為Diagnostics & Research。
    Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
    截至10/08 09:30:01,Agilent Technologies的股價升2.90,市值39,599.73百萬。Agilent Technologies的市盈率及息率分別為32.020及0.62%。
    詳細公司背景可參考: https://www.agilent.com